These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 445517)

  • 1. The kinetics of Sézary cell production.
    Shackney SE; Edelson R; Bunn PA
    Cancer Treat Rep; 1979 Apr; 63(4):659-61. PubMed ID: 445517
    [No Abstract]   [Full Text] [Related]  

  • 2. Sezary syndrome: diagnosis and management.
    Ogilvie C; Jackson R; Leach M; McKay P
    J R Coll Physicians Edinb; 2012; 42(4):317-21. PubMed ID: 23240118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sézary cells].
    Kozinets GI; Lezvinskaia EM; Persina IS
    Probl Gematol Pereliv Krovi; 1980 Apr; 25(4):44-9. PubMed ID: 6966799
    [No Abstract]   [Full Text] [Related]  

  • 4. Multicompartment analysis of cell proliferation and cell migration in the Sezary syndrome.
    Shackney SE; Schuette WH
    Hematol Oncol; 1983; 1(1):31-48. PubMed ID: 6677561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sézary syndrome. A malignant leukemic reticuloendotheliosis.
    Tedeschi LG; Lansinger DT
    Arch Dermatol; 1965 Sep; 92(3):257-62. PubMed ID: 11851246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Sézary cells. A new preparatory method for their identification and enumeration.
    Fletcher V; Zackheim HS; Beckstead JH
    Arch Pathol Lab Med; 1984 Dec; 108(12):954-8. PubMed ID: 6239604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sézary's syndrome (author's transl)].
    Ruelens A; Sztern B; Bar JP; De Dobeleer G; De Saint Georges A; Feremans W; Salhadin A
    Rev Med Brux; 1981 Sep; 2(7):635-9. PubMed ID: 6975495
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent developments in cutaneous lymphoproliferative disorders.
    Slater DN
    J Pathol; 1987 Sep; 153(1):5-19. PubMed ID: 3312549
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant and nonmalignant T cell lines from human T cell lymphotropic virus type I-negative patients with Sézary syndrome.
    Abrams JT; Lessin SR; Ghosh SK; Nowell PC; Ju W; Vonderheid EC; Rook AH; DeFreitas E
    J Immunol; 1991 Mar; 146(5):1455-62. PubMed ID: 1847162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sézary syndrome.
    Sauder DN; Bergfeld WF
    Cutis; 1979 Jan; 23(1):39-42. PubMed ID: 759119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advances in American dermatology].
    Hollander A
    Hautarzt; 1982 Apr; 33(4):191-200. PubMed ID: 6980211
    [No Abstract]   [Full Text] [Related]  

  • 12. Sezary cell: characterisation by a biophysical parameter.
    Wioland M; Najman A
    Biomedicine; 1979 Apr; 31(2):29-30. PubMed ID: 314310
    [No Abstract]   [Full Text] [Related]  

  • 13. Light-microscopic analysis of sectioned Sézary cells: an accurate alternative to electron microscopy.
    Myrie C; Zucker-Franklin D; Ramsey D
    Am J Pathol; 1980 Apr; 99(1):243-52. PubMed ID: 7361860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral bexarotene in a therapy-resistant Sézary syndrome patient: observations on Sézary cell compartmentalization.
    el-Azhary RA; Bouwhuis SA
    Int J Dermatol; 2005 Jan; 44(1):25-8. PubMed ID: 15663654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sezary lineage cells can be induced to proliferate via CD28-mediated costimulation.
    McCusker ME; Garifallou M; Bogen SA
    J Immunol; 1997 May; 158(10):4984-91. PubMed ID: 9144518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sézary syndrome: a model for migration of T lymphocytes to skin.
    Miller RA; Coleman CN; Fawcett HD; Hoppe RT; McDougall IR
    N Engl J Med; 1980 Jul; 303(2):89-92. PubMed ID: 6966761
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of apoptosis of Sézary cells in the circulation following oral bexarotene therapy.
    Brennand S; Sutton VR; Biagi J; Trapani JA; Westerman D; McCormack CJ; Seymour JF; Kennedy G; Prince HM
    Br J Dermatol; 2005 Jun; 152(6):1199-205. PubMed ID: 15948982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
    López-Lerma I; Estrach MT
    J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sézary syndrome.
    Kelemen K; Guitart J; Kuzel TM; Goolsby CL; Peterson LC
    Am J Clin Pathol; 2008 Jan; 129(1):146-56. PubMed ID: 18089499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pre-Sézary erythroderma developing into Sézary syndrome: apropos of 2 observations].
    Soria C; Ledo E; Sendagorta E; Ledo A; Rocamora A
    Med Cutan Ibero Lat Am; 1988; 16(5):403-6. PubMed ID: 2976867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.